PFIZER INC
NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 12, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$164.2M2026 Q3
Positions17
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.95.1%
What Changed This Quarter?
Top Holdings
ALLO
Allogene Therapeutics
22.1%
ARVN
Arvinas
16.0%
CELC
Celcuity
14.3%
AGMB
AgomAb Therapeutics
13.8%
PYXS
Pyxis Oncology
12.2%
WVE
Wave Life Sciences
4.3%
BHVN
Biohaven
4.0%
CRBU
Caribou Biosciences
3.5%
New / Increased
2 new · 2 increased
WVENEW
Wave Life Sciences
4.3%
SENSNEW
Senseonics
0.0%
AGMB
Agomab Therapeutics
13.8%
+2768.3%
Nextcure
Nextcure
0.1%
0.0%
Reduced / Exited
0 reduced · 2 sold out
96663EUREXIT
Wave Life Sciences
6.4%
SenseonicsEXIT
Senseonics
0.0%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.